Balance Sheet
Accounts PayablesAssetsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Polomar Health Services (PMHS) Cash & Equivalents (2022 - 2025)

Polomar Health Services has reported Cash & Equivalents over the past 4 years, most recently at $129331.0 for Q1 2025.

  • Quarterly results put Cash & Equivalents at $129331.0 for Q1 2025, up 362.01% from a year ago — trailing twelve months through Mar 2025 was $129331.0 (up 362.01% YoY), and the annual figure for FY2023 was $8808.0, down 96.1%.
  • Cash & Equivalents for Q1 2025 was $129331.0 at Polomar Health Services, up from $16202.0 in the prior quarter.
  • Over the last five years, Cash & Equivalents for PMHS hit a ceiling of $225619.0 in Q4 2022 and a floor of $4604.0 in Q3 2022.
  • Median Cash & Equivalents over the past 4 years was $28006.0 (2023), compared with a mean of $69531.4.
  • Peak annual rise in Cash & Equivalents hit 693.79% in 2023, while the deepest fall reached 96.1% in 2023.
  • Polomar Health Services' Cash & Equivalents stood at $225619.0 in 2022, then plummeted by 96.1% to $8808.0 in 2023, then soared by 83.95% to $16202.0 in 2024, then skyrocketed by 698.24% to $129331.0 in 2025.
  • The last three reported values for Cash & Equivalents were $129331.0 (Q1 2025), $16202.0 (Q3 2024), and $19857.0 (Q2 2024) per Business Quant data.